Thioredoxin-1 (Trx1) engineered mesenchymal stem cell therapy is a promising feasible therapeutic approach for myocardial infarction-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Thioredoxin-1 (Trx1) engineered mesenchymal stem cell therapy is a promising feasible therapeutic approach for myocardial infarction

Published:2016-03 Issue: Volume:206 Page:169-170
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Yang Chao-Jun,Yang Jun,Yang Jian,Fan Zhi-Xing

Funder

National Natural Science Foundation of China

Hubei Province's Science Technology Support program

Hubei Province's Outstanding Medical Academic Leader program

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference15 articles.

1. Thioredoxin-1 (Trx1) engineered mesenchymal stem cell therapy increased pro-angiogenic factors, reduced fibrosis and improved heart function in the infarcted rat myocardium;Suresh;Int J Cardiol,2015

2. Stem cell repair of infarcted myocardium: an overview for clinicians;Forrester;Circulation,2003

3. Stem-cell therapy for cardiac disease;Segers;Nature,2008

4. Stem cells for the treatment of cardiovascular diseases, an update;Bartolucci;Rev Med Chil,2014

5. Autologous mesenchymal stem cells show more benefit on systolic function compared to bone marrow mononuclear cells in a porcine model of chronic myocardial infarction;van der Spoel;J Cardiovasc Transl Res,2015

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Schizophrenia Plays a Negative Role in the Pathological Development of Myocardial Infarction at Multiple Biological Levels;Frontiers in Genetics;2021-06-03

2. Functionally Improved Mesenchymal Stem Cells to Better Treat Myocardial Infarction;Stem Cells International;2018-11-25

3. Reply to the letter “thioredoxin-1 (Trx1) engineered mesenchymal stem cell therapy is a promising feasible therapeutic approach for myocardial infarction”;International Journal of Cardiology;2016-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3